OVID
Ovid Therapeutics (OVID)
$
67About Ovid Therapeutics (OVID)
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Details
Daily high
$0.71
Daily low
$0.67
Price at open
$0.70
52 Week High
$4.10
52 Week Low
$0.65
Market cap
47.6M
Dividend yield
0.00%
Volume
188,030
Avg. volume
481,825
P/E ratio
-1.46
Ovid Therapeutics News
Details
Daily high
$0.71
Daily low
$0.67
Price at open
$0.70
52 Week High
$4.10
52 Week Low
$0.65
Market cap
47.6M
Dividend yield
0.00%
Volume
188,030
Avg. volume
481,825
P/E ratio
-1.46